Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma

BACKGROUND: Recently, PFTK1 was identified as a member of the cyclin-dependent kinase family; however, its expression and clinical significance in oesophageal squamous cell carcinoma (ESCC) have not been evaluated. METHODS: PFTK1 expression was initially examined by expression microarray in 77 ESCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagaki, H, Yamasaki, M, Miyata, H, Takahashi, T, Kurokawa, Y, Nakajima, K, Takiguchi, S, Fujiwara, Y, Ishii, H, Tanaka, F, Mori, M, Doki, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305960/
https://www.ncbi.nlm.nih.gov/pubmed/22333595
http://dx.doi.org/10.1038/bjc.2012.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305960/
https://www.ncbi.nlm.nih.gov/pubmed/22333595
http://dx.doi.org/10.1038/bjc.2012.35

Ejemplares similares